Cargando…

β-Amyloid Degradation and Alzheimer's Disease

Extensive β-amyloid (Aβ) deposits in brain parenchyma in the form of senile plaques and in blood vessels in the form of amyloid angiopathy are pathological hallmarks of Alzheimer's disease (AD). The mechanisms underlying Aβ deposition remain unclear. Major efforts have focused on Aβ production,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Deng-Shun, Dickson, Dennis W., Malter, James S.
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2006
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1559921/ https://www.ncbi.nlm.nih.gov/pubmed/17047308 http://dx.doi.org/10.1155/JBB/2006/58406

Ejemplares similares

Mitochondria, Amyloid β, and Alzheimer's Disease
por: Readnower, Ryan D., et al.
Publicado: (2011)

The Amyloid-β Pathway in Alzheimer’s Disease
por: Hampel, Harald, et al.
Publicado: (2021)

Amyloid β-protein oligomers and Alzheimer’s disease
por: Hayden, Eric Y, et al.
Publicado: (2013)

Immunotherapy for Alzheimer’s disease: targeting β-amyloid and beyond
por: Song, Chenghuan, et al.
Publicado: (2022)

Redox-Active Metal Ions and Amyloid-Degrading Enzymes in Alzheimer’s Disease
por: Kim, Namdoo, et al.
Publicado: (2021)

Evidence for impaired amyloid β clearance in Alzheimer's disease
por: Wildsmith, Kristin R, et al.
Publicado: (2013)

Metabolism of amyloid β peptide and pathogenesis of Alzheimer’s disease
por: SAIDO, Takaomi C.
Publicado: (2013)

Is pathological aging a successful resistance against amyloid-beta or preclinical Alzheimer’s disease?
por: Murray, Melissa E, et al.
Publicado: (2014)

Impaired hepatic amyloid-beta degradation in Alzheimer’s disease
por: Maarouf, Chera L., et al.
Publicado: (2018)

The amyloid hypothesis of Alzheimer's disease at 25 years
por: Selkoe, Dennis J, et al.
Publicado: (2016)

Brain amyloid β protein and memory disruption in Alzheimer’s disease
por: Xia, Weiming
Publicado: (2010)

β-Amyloid and the Pathomechanisms of Alzheimer’s Disease: A Comprehensive View
por: Penke, Botond, et al.
Publicado: (2017)

Cellular Receptors of Amyloid β Oligomers (AβOs) in Alzheimer’s Disease
por: Mroczko, Barbara, et al.
Publicado: (2018)

Trans-Synaptic Spread of Amyloid-β in Alzheimer's Disease: Paths to β-Amyloidosis
por: Pignataro, Annabella, et al.
Publicado: (2017)

The Alzheimer's Amyloid-Degrading Peptidase, Neprilysin: Can We Control It?
por: Nalivaeva, N. N., et al.
Publicado: (2012)

Microglia receptors and their implications in the response to amyloid β for Alzheimer’s disease pathogenesis
por: Doens, Deborah, et al.
Publicado: (2014)

Apolipoprotein E as a β-amyloid-independent factor in Alzheimer’s disease
por: Wolf, Andrew B, et al.
Publicado: (2013)

Interpreting Alzheimer’s disease clinical trials in light of the effects on amyloid-β
por: Toyn, Jeremy H, et al.
Publicado: (2014)

Vaccination against β-Amyloid as a Strategy for the Prevention of Alzheimer’s Disease
por: Mantile, Francesca, et al.
Publicado: (2020)

Comparison of Tau and Amyloid-β Targeted Immunotherapy Nanoparticles for Alzheimer’s Disease
por: Mashal, Yara, et al.
Publicado: (2022)

Alzheimer’s Disease: A Brief History of Immunotherapies Targeting Amyloid β
por: Vogt, Anne-Cathrine S., et al.
Publicado: (2023)

The Hidden Role of Non-Canonical Amyloid β Isoforms in Alzheimer’s Disease
por: Busch, Lukas, et al.
Publicado: (2022)

Plasma β-amyloid in Alzheimer’s disease and vascular disease
por: Janelidze, Shorena, et al.
Publicado: (2016)

The amyloid-β degradation intermediate Aβ34 is pericyte-associated and reduced in brain capillaries of patients with Alzheimer’s disease
por: Kirabali, Tunahan, et al.
Publicado: (2019)

Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer’s Disease Therapeutics
por: Jeong, Hyomin, et al.
Publicado: (2022)

Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
por: Zhang, Yun, et al.
Publicado: (2023)

The neuropathological diagnosis of Alzheimer’s disease
por: DeTure, Michael A., et al.
Publicado: (2019)

β-Amyloid oligomers in aging and Alzheimer’s disease
por: Zahs, Kathleen R., et al.
Publicado: (2013)

Potential Therapeutic Strategies for Alzheimer's Disease Targeting or Beyond β-Amyloid: Insights from Clinical Trials
por: Jia, Qiutian, et al.
Publicado: (2014)

Prominent tauopathy and intracellular β-amyloid accumulation triggered by genetic deletion of cathepsin D: Implications for Alzheimer disease pathogenesis
por: Terron, Heather M., et al.
Publicado: (2023)

Heterogeneous Association of Alzheimer’s Disease-Linked Amyloid-β and Amyloid-β Protein Precursor with Synapses
por: Willén, Katarina, et al.
Publicado: (2017)

β-Amyloid: the key peptide in the pathogenesis of Alzheimer’s disease
por: Sun, Xiaojuan, et al.
Publicado: (2015)

Immunotherapy for the treatment of Alzheimer’s disease: amyloid-β or tau, which is the right target?
por: Castillo-Carranza, Diana L, et al.
Publicado: (2013)

Amyloid β and free heme: bloody new insights into the pathogenesis of Alzheimer’s disease
por: Flemmig, Jörg, et al.
Publicado: (2018)

Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease
por: Morris, Gary P., et al.
Publicado: (2018)

The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer’s Disease
por: Poejo, Joana, et al.
Publicado: (2021)

Alzheimer’s Disease: A Molecular View of β-Amyloid Induced Morbific Events
por: Mohamed Asik, Rajmohamed, et al.
Publicado: (2021)

Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease
por: Campos-Peña, Victoria, et al.
Publicado: (2022)

Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2020)

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease
por: Querol-Vilaseca, Marta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ou8t9crrrapo65g3iom2qqhc0h